Evidence map›Paper›PMID 34128429›Full record

ArticlePalliative medicine2021

Development and validation of a prediction model of poor performance status and severe symptoms over time in cancer patients (PROVIEW+).

Hsien Seow, Peter Tanuseputro, Lisa Barbera, Craig C Earle, Dawn M Guthrie, Sarina R Isenberg, Rosalyn A Juergens, Jeffrey Myers, Melissa Brouwers, Semra Tibebu and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Palliative medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Hsien SeowDepartment of Oncology, McMaster University, Hamilton, ON, Canada.ORCID https://orcid.org/0000-0001-6701-1714
Peter TanuseputroDivision of Palliative Care, Department of Medicine, Ottawa Hospital Research Institute, Ottawa, ON, Canada.ORCID https://orcid.org/0000-0002-4409-0795
Lisa BarberaDepartment of Oncology, University of Calgary, Calgary, AB, Canada.
Craig C EarleInstitute for Clinical Evaluative Sciences, Toronto, ON, Canada.
Dawn M GuthrieDepartment of Kinesiology and Physical Education and Department of Health Sciences, Wilfrid Laurier University, Waterloo, ON, Canada.
Sarina R IsenbergDivision of Palliative Care, Department of Medicine, Ottawa Hospital Research Institute, Ottawa, ON, Canada.ORCID https://orcid.org/0000-0001-6059-5366
Rosalyn A JuergensDepartment of Oncology, McMaster University, Hamilton, ON, Canada.
Jeffrey MyersDivision of Palliative Care, Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.
Melissa BrouwersSchool of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.
Semra TibebuInstitute for Clinical Evaluative Sciences, Toronto, ON, Canada.
Rinku SutradharInstitute for Clinical Evaluative Sciences, Toronto, ON, Canada.
Institute for Clinical Evaluative Sciences · CAOttawa Hospital · CAUniversity of Toronto · CAAlberta Health Services · CAMcMaster University · CAUniversity of Ottawa · CAWilfrid Laurier University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPredictive cancer tools focus on survival; none predict severe symptoms.

aimTo develop and validate a model that predicts the risk for having low performance status and severe symptoms in cancer patients.

designRetrospective, population-based, predictive study. SETTING/

participantsWe linked administrative data from cancer patients from 2008 to 2015 in Ontario, Canada. Patients were randomly selected for model derivation (60%) and validation (40%). Using the derivation cohort, we developed a multivariable logistic regression model to predict the risk of an outcome at 6 months following diagnosis and recalculated after each of four annual survivor marks. Model performance was assessed using discrimination and calibration plots. Outcomes included low performance status (i.e. 10-30 on Palliative Performance Scale), severe pain, dyspnea, well-being, and depression (i.e. 7-10 on Edmonton Symptom Assessment System).

resultsWe identified 255,494 cancer patients (57% female; median age of 64; common cancers were breast (24%); and lung (13%)). At diagnosis, the predicted risk of having low performance status, severe pain, well-being, dyspnea, and depression in 6-months is 1%, 3%, 6%, 13%, and 4%, respectively for the reference case (i.e. male, lung cancer, stage I, no symptoms); the corresponding discrimination for each outcome model had high AUCs of 0.807, 0.713, 0.709, 0.790, and 0.723, respectively. Generally these covariates increased the outcome risk by >10% across all models: lung disease, dementia, diabetes; radiation treatment; hospital admission; pain; depression; transitional performance status; issues with appetite; or homecare.

conclusionsThe model accurately predicted changing cancer risk for low performance status and severe symptoms over time.

Indexed as

Lung NeoplasmsDyspneaFemaleHumansMaleOntarioPrognosisRetrospective StudiesADLCancerdepressiondyspnealogistic modelpainpalliative careprognosis

Identifiers

PMID34128429
PMCPMC8532207
OpenAlexW3167277300

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.